List view / Grid view

News

Pfizer presents new Phase 3 data

18 May 2011 | By Pfizer

Pfizer Inc. announced data from the pivotal Phase 3 AXIS 1032 trial. Patients with previously treated advanced RCC, axitinib extended progression-free survival...

Phase II Study Results

18 May 2011 | By AstraZeneca

AstraZeneca announced encouraging results from a phase II study in patients with platinum-sensitive relapsed serous ovarian cancer...